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Background
Slow conduction and ectopic activity are major determi-
nants of cardiac arrhythmogenesis. Both of these condi-
tions can be elicited by myofibroblasts (MFBs) following
establishment of heterocellular gap junctional coupling
with cardiomyocytes. MFBs appear during structural
remodeling of the heart and are characterized by the
expression of α-smooth muscle actin (α-SMA) containing
stress fibers. In this study, we investigated whether phar-
macological interference with the actin cytoskeleton
affects myofibroblast arrhythmogeneicity.
Methods
Experiments were performed with patterned growth
strands of neonatal rat ventricular cardiomyocytes coated
with cardiac MFBs. Impulse conduction velocity (θ) and
maximal upstroke velocities of propagated action poten-
tials (dV/dtmax), expressed as % action potential ampli-
tude change (%APA) per ms, were measured optically
using voltage sensitive dyes. Actin was destabilized by
latrunculin B (LtB) and cytochalasin D and stabilized with
jasplakinolide. Data are given as mean ± S.D. (n = 5-22).
Single cell electrophysiology was assessed using standard
patch-clamp techniques.
Results
As revealed by immunocytochemistry, exposure of MFBs
to LtB (0.01-10 μmol/L) profoundly disrupted stress fib-
ers which led to drastic changes in cell morphology with
MFBs assuming an astrocyte-like shape. In control cardio-
myocyte strands (no MFB coat), LtB had negligible effects
on θ and dV/dtmax. In contrast, LtB applied to MFB-coated
strands increased θ dose-dependently from 197 ± 35 mm/
s to 344 ± 26 mm/s and dV/dtmax from 38 ± 5 to 78 ± 3%
APA/ms, i.e., to values virtually identical to those of cardi-
omyocyte control strands (339 ± 24 mm/s; 77 ± 3% APA/
ms). Highly similar results were obtained when exposing
the preparations to cytochalasin D. In contrast, stabiliza-
tion of actin with increasing concentrations of jasplakino-
lide exerted no significant effects on impulse conduction
characteristics in MFB-coated strands. Whole-cell patch-
clamp experiments showed that LtB hyperpolarized MFBs
from -25 mV to -50 mV, thus limiting their depolarizing
effect on cardiomyocytes which was shown before to
cause arrhythmogenic slow conduction and ectopic activ-
ity.
Conclusion
Pharmacological interference with the actin cytoskeleton
of cardiac MFBs affects their electrophysiological pheno-
type to such an extent that they loose their detrimental
effects on cardiomyocyte electrophysiology. This result
might form a basis for the development of therapeutic
strategies aimed at limiting the arrhythmogenic potential
of MFBs.
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